导师姓名： 麻静 专业代码： 100201
性别： 女 专业名称： 内科学
培养单位： 附属仁济医院 三级学科/
专业领域： 内分泌与代谢病
导师类型： 硕士生导师 专业学位导师： 兼
联系方式：
邮编： 邮箱地址： cherry1996@live.cn

研究方向 (点击浏览详细信息)
胃肠功能与能量代谢的调控

社会任职
上海医学会内分泌分会肥胖学组成员
中华医学会内分泌分会肝病与代谢学组成员
上海微生物学会会员
上海医学会内分泌分会委员

科研项目 项目编号项目名称课题来源起止年月批准经费承担职责
CHDI-2019-A-01 2型糖尿病胃肠并发症管理模式的探索 上海交通大学中国医院发展研究院医院管理建设项目 2019-08~2021-08 9万元 课题负责人
2019PJD027 人造甜味剂在甜味受体信号通路调控脂肪细胞分化及肥胖发生中的作用 上海人力资源社会保障局 2019-07~2021-06 30万元 课题负责人
** 人造甜味剂对于2型糖尿病患者糖代谢影响 上海市教委-高原高峰之双**** 2018-10~2021-09 100万元 课题负责人
** 肠道甜味受体信号通路在胃肠激素分泌和2型糖尿病中的作用与机制 国家自然科学基金 2017-01~2020-12 62万元 课题负责人
2016PWZH01 人造甜味剂三氯蔗糖对2型糖尿病肠道甜味受体及肠道激素影响的研究 上海交通大学医学院附属仁济医院南院院内科研培育项目 2016-08~2018-07 7万元 课题负责人
PYZY16-020 α-糖苷酶抑制剂对于2型糖尿病肠道甜味受体及肠道激素影响的研究 上海交通大学医学院附属仁济医院临床科研创新培育基金计划 2016-06~2019-05 10万元 课题负责人
** 静脉血与指尖血及肾病患者对MQ-6000检测糖化血红蛋白的影响分析 上海市科委 2015-10~2017-09 10万元 课题负责人
** 环境内分泌干扰物AGEs在多囊卵巢综合征发病机制中的研究 国家自然科学基金面上项目 2015-01~2018-12 67万元 课题参与人
** 阿卡波糖与西格列汀治疗对于糖尿病患者肠促胰素分泌的影响 上海市卫生局 2013-01~2015-12 6万元 课题负责人
** 硫酸脱氢表雄酮对脂肪功能的影响及其在多囊卵巢综合征发病中的作用 国家自然科学基金面上项目 2013-01~2016-12 65万元 课题参与人

学术论文 作者论文标题期刊名出版年卷期页码
Ma J, Wan X, Wu B The Cost-Effectiveness of Lifestyle Interventions for Preventing Diabetes in a Health Resource-Limited Setting J Diabetes Res 2020 2020:**
Shi F,Shen L,Pan M, Ma L,Zhang C,Gu Z,Ma J （通讯作者）,Li H The Successful Rapid Adjustment of Blood Glucose in a Patient With Acute Coronary Syndrome, Renal Insufficiency, and Diabetes: A Case Report of Management Coordinated by Clinical Pharmacists and Clinicians Front Pharmacol 2020 2020.00756
Zhang M, Feng R, Yue J, Qian C, Yang M, Liu W, Rayner CK, Ma J （通讯作者） Effects of Metformin and Sitagliptin Monotherapy on Expression of Intestinal and Renal Sweet Taste Receptors and Glucose Transporters in a Rat Model of Type 2 Diabetes Horm Metab Res 2020 52(5):329-335
Xue J, Liu W, Shi F, Zheng J, Ma J （通讯作者） Pleural Effusion Due to Use of Pioglitazone: A Case Report. Metab Syndr Relat Disord. Metab Syndr Relat Disord 2020 18(3):168-171
Jiang Y, Wang L, Shi F, Zhou H, Zheng J, Cai J, Yang S, Ma J （通讯作者）, Liu W. Insulin Autoimmune Syndrome After Exposure to Clopidogrel: A Case Report Endocr Metab Immune Disord Drug Targets 2019 published online ahead of print
Zhang M, Feng R, Yang M, Qian C, Wang Z, Liu W, Ma J （通讯作者） Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats. BMJ Open Diabetes Res Care. 2019 7(1):e000717
Shi FH, Li H, Shen L, Zhang Z, Jiang YH, Hu YM, Liu XY, Gu ZC, Ma J. （通讯作者） Appraisal of Non-Cardiovascular Safety for Sodium-Glucose Co-Transporter 2 Inhibitors: A Systematic Review and Meta-Analysis of Placebo-Controlled Randomized Clinical Trials. Front Pharmacol. 2019 10:1066
Yang M, Liu Y, Wen CH, Wu BR, Wan X, Luan W, Shen J, Liu W, Ma J. （通讯作者） Association between spousal diabetes status and diabetic retinopathy in Chinese patients with type 2 diabetes. Diab Vasc Dis Res. 2019 16(5):474-477
Feng RL, Qian C, Liu LY, Liu QJ, Jin YQ, Li SX, Liu W, Rayner CK, Ma J. （通讯作者） Secretion of Gut Hormones and Expression of Sweet Taste Receptors and Glucose Transporters in a Rat Model of Obesity. Obes Facts. 2019 12:190–198
Wang S, Deng Y, Xie X, Ma J （共同第一作者）, Xu M, Zhao X, Gu W, Hong J, Wang W, Xu G, Ning G, Gu Y, Zhang Y. The plasma bile acid alterations of Type 2 diabetes correlated with insulin secretion in two-stephyperglycemic clamp J Diabetes. 2018 (10)1753-1757
Wu B, Wan X, Ma J. （通讯作者） Cost-effectiveness of prevention and management of diabetic foot ulcer and amputation in a health resource-limited setting J Diabetes. 2018 10(4):320-327.
Ma J, Vella A. What Has Bariatric Surgery Taught Us About the Role of the Upper Gastrointestinal Tract in the Regulation of Postprandial Glucose Metabolism? Front Endocrinol (Lausanne). 2018 9:324
Li S, Chu Q, Ma J （共同第一作者）, Sun Y, Tao T, Huang R, Liao Y, Yue J, Zheng J, Wang L, Xue X, Zhu M, Kang X, Yin H, Liu W. Discovery of novel lipid profiles in PCOS: Do insulin and androgen oppositely regulate bioactive lipid production? J Clin Endocrinol Metab. 2017 102(3):810-821
Gu Y,Wang X,Li J,Zhang Y,Zhong H,Liu R,Zhang D,Feng Q,Xie X,Hong J,Ren H,Liu W,Ma J,Su Q,Zhang H,Yang J,Wang X,Zhao X,Gu W,Bi Y,Peng Y,Xu X,Xia H,Li F,Xu X,Yang H,Xu G,Madsen L,Kristiansen K,Ning G,Wang W. Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment Nat Commun. 2017 8(1):1785.
Feng RL, Qian C, Liu QJ, Jin YQ, Liu LY, Li SX, Zhou H, Liu W, Rayner CK, Ma J. （通讯作者） Expression of sweet taste receptor and gut hormone secretion in modelled type 2 diabetes General and Comparative Endocrinology 2017 252c:142-149
Ma J,Zhou H,Xu H,Chen X,Teng XY,Liu QJ,Liu W. The initial assessment of daily insulin dose in Chinese newly diagnosed Type 2 Diabetes J Diabetes Res. 2016 2016
Ma J, Jesudason DR, Stevens JE, Keogh JB, Jones KL, Clifton PM, Horowitz M, Rayner CK. Sustained effects of a protein 'preload' on glycaemia and gastric emptying over 4 weeks in patients with type 2 diabetes: A randomized clinical trial. Diabetes Res Clin Pract. 2015 108(2):e31-4
Lin TC,Li SX,Xu H,Zhou H,Feng RL,Liu W,Sun Y,Ma J. （通讯作者） Gastrointestinal hormone secretion in women with polycystic ovary syndrome: an observational study Human Reproduction 2015 30(11):2639–2644
Ma J, Liu LY, Wu PH, Liao Y, Tao T, Liu W. Comparison of metformin and repaglinide monotherapy in the treatment of new onset type 2 diabetes mellitus in China. J Diabetes Res. 2014 2014:294017
Ma J, Lin TC, Liu W. Gastrointestinal hormones and polycystic ovary syndrome. Endocrine. 2014 47(3):668-78
Ma J, Checklin HL, Wishart JM, Stevens JE, Jones KL, Horowitz M, Meyer JH,Rayner CK. A randomized trialofenteric-coated nutrient pellets to stimulate gastrointestinal peptide release and lower glycaemia in type 2 diabetes. Diabetologia. 2013 56(6):1236-42
Ma J, Pilichiewicz AN, Feinle-Bisset C, Wishart JM, Jones KL, Horowitz M, Rayner CK Effects of variations in duodenal glucose load on glycaemic, insulin, and incretin responses in type 2 diabetes. Diabet Med. 2012 29(5):604-8
Ma J,Pilichiewicz AN,Feinle-Bisset C,Wishart JM,Jones KL,Horowitz M,Rayner CK. Effects of variations in duodenal glucose load on glycaemic, insulin, and incretin responses in type 2 diabetes Diabetic Medicine 2011 29(5):604-608
Ma J,Chang J,Checklin HL,Young RL,Jones KL,Horowitz M,Rayner CK. Effect of the artificial sweetener, sucralose, on small intestinal glucose absorption in healthy human subjects British Journal of Nutrition 2010 104(6):803-806
Ma J,Bellon M,Wishart JM,Young RL,Jones KL,Horowitz M,Rayner CK. Effects of cefaclor on gastric emptying and cholecystokinin release in healthy humans Regulatory Peptides 2010 159 (1-3):156–159
Ma J, Bellon M, Wishart JM, Young R, Blackshaw LA, Jones KL, Horowitz M, Rayner CK. Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects Am J Physiol Gastrointest Liver Physiol 2009 296(4):G735-9
Ma J, Rayner CK, Jones KL, Horowitz M. Insulin secretion in healthy subjects and patients with Type 2 diabetes--role of the gastrointestinal tract. Best Pract Res Clin Endocrinol Metab. 2009 23(4):413-424
Ma J, Stevens JE, Cukier K, Maddox AF, Wishart JM, Jones KL, Clifton PM, Horowitz M, Rayner CK. Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes. Diabetes Care 2009 32(9):1600-1602
Ma J, Rayner CK, Jones KL,Horowitz M. Diabetic gastroparesis: diagnosis and management. Drugs 2009 69(8):971-986
Ma J, Ma Z, Wang J, Milne RW, Xu D, Davey AK, Evans AM. Isosteviol reduces plasma glucose levels in the intravenous glucose tolerance test in Zucker diabetic fatty rats. Diabetes Obes Metab 2007 9(4):597-9